This company has been marked as potentially delisted and may not be actively trading. Leisure Acquisition (LACQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LACQ vs. ATNM, NBRV, AADI, EGRX, PYRGF, NNVC, TAOX, IBIO, NBY, and ETHZShould you be buying Leisure Acquisition stock or one of its competitors? The main competitors of Leisure Acquisition include Actinium Pharmaceuticals (ATNM), Nabriva Therapeutics (NBRV), Aadi Bioscience (AADI), Eagle Pharmaceuticals (EGRX), PyroGenesis Canada (PYRGF), NanoViricides (NNVC), Synaptogenix (TAOX), iBio (IBIO), NovaBay Pharmaceuticals (NBY), and Flag Ship Acquisition (ETHZ). Leisure Acquisition vs. Its Competitors Actinium Pharmaceuticals Nabriva Therapeutics Aadi Bioscience Eagle Pharmaceuticals PyroGenesis Canada NanoViricides Synaptogenix iBio NovaBay Pharmaceuticals Flag Ship Acquisition Actinium Pharmaceuticals (NYSE:ATNM) and Leisure Acquisition (NASDAQ:LACQ) are both small-cap pharmaceutical preparations industry companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends, media sentiment and valuation. Is ATNM or LACQ more profitable? Leisure Acquisition's return on equity of 30.17% beat Actinium Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Actinium PharmaceuticalsN/A -100.85% -47.89% Leisure Acquisition N/A 30.17%6.14% Which has higher valuation & earnings, ATNM or LACQ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioActinium PharmaceuticalsN/AN/A-$48.82M-$1.31-1.24Leisure AcquisitionN/AN/A$4.31MN/AN/A Which has more volatility & risk, ATNM or LACQ? Actinium Pharmaceuticals has a beta of -0.3, indicating that its share price is 130% less volatile than the S&P 500. Comparatively, Leisure Acquisition has a beta of -0.3, indicating that its share price is 130% less volatile than the S&P 500. Do institutionals & insiders believe in ATNM or LACQ? 27.5% of Actinium Pharmaceuticals shares are held by institutional investors. Comparatively, 56.7% of Leisure Acquisition shares are held by institutional investors. 6.0% of Actinium Pharmaceuticals shares are held by company insiders. Comparatively, 39.6% of Leisure Acquisition shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts prefer ATNM or LACQ? Actinium Pharmaceuticals currently has a consensus target price of $4.50, indicating a potential upside of 176.07%. Given Actinium Pharmaceuticals' stronger consensus rating and higher probable upside, equities analysts clearly believe Actinium Pharmaceuticals is more favorable than Leisure Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Actinium Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Leisure Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer ATNM or LACQ? In the previous week, Actinium Pharmaceuticals had 1 more articles in the media than Leisure Acquisition. MarketBeat recorded 1 mentions for Actinium Pharmaceuticals and 0 mentions for Leisure Acquisition. Actinium Pharmaceuticals' average media sentiment score of 1.46 beat Leisure Acquisition's score of -1.38 indicating that Actinium Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Actinium Pharmaceuticals Positive Leisure Acquisition Negative SummaryActinium Pharmaceuticals and Leisure Acquisition tied by winning 5 of the 10 factors compared between the two stocks. Get Leisure Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for LACQ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LACQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LACQ vs. The Competition Export to ExcelMetricLeisure AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$13.13M$736.37M$2.41B$10.14BDividend YieldN/A4.84%13.78%4.60%P/E RatioN/A1.1725.4025.98Price / SalesN/A26.6412,660.08181.13Price / Cash20.0319.5660.0160.44Price / Book-11.116.683.166.29Net Income$4.31M-$4.13M-$445.27M$271.07M Leisure Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LACQLeisure AcquisitionN/A$2.11-0.9%N/A+569.8%$13.13MN/A0.00N/ANegative NewsHigh Trading VolumeATNMActinium Pharmaceuticals3.0632 of 5 stars$1.65+2.2%$4.50+173.6%-12.4%$51.32MN/A-1.1830Positive NewsShort Interest ↑NBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070AADIAadi BioscienceN/A$1.80+0.6%N/A+10.6%$44.46M$25.07M-0.7940EGRXEagle PharmaceuticalsN/A$3.21flatN/A-25.5%$41.69M$257.55M0.00100Gap DownPYRGFPyroGenesis CanadaN/A$0.18+1.4%N/A-67.9%$33.25M$9.14M-2.9690Gap UpHigh Trading VolumeNNVCNanoViricides0.1492 of 5 stars$1.43flatN/A-9.4%$22.98MN/A-1.9920Short Interest ↑TAOXSynaptogenix0.1116 of 5 stars$6.04-8.3%N/AN/A$21.08MN/A-0.304IBIOiBio1.6767 of 5 stars$0.94+6.3%$5.00+433.0%-51.1%$18.44M$375K-0.54100Short Interest ↑Gap DownNBYNovaBay Pharmaceuticals0.4106 of 5 stars$2.71+12.4%$0.85-68.6%+445.4%$15.78M$9.78M-0.0530Gap UpETHZFlag Ship AcquisitionN/A$2.42-2.0%N/AN/A$14.62MN/A-0.167 Related Companies and Tools Related Companies ATNM Alternatives NBRV Alternatives AADI Alternatives EGRX Alternatives PYRGF Alternatives NNVC Alternatives TAOX Alternatives IBIO Alternatives NBY Alternatives ETHZ Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LACQ) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina’s message to TrumpDid China just fire shots at America? Last week, in Tiananmen Square, China put on a chilling display of mi...Porter & Company | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leisure Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leisure Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LACQ Stock Alerts